AR033624A1 - Derivados del dihidro-imidazo[4,5-e]indol y de la 7h-pirrolo[3,2-f]quinoxalina en calidad de ligandos nicotinicos del receptor para acetilcolina y/o de ligandos serotoninergicos, un procedimiento para su preparacion, las composiciones farmaceuticas que los contienen, y el empleo de los mismos para p - Google Patents
Derivados del dihidro-imidazo[4,5-e]indol y de la 7h-pirrolo[3,2-f]quinoxalina en calidad de ligandos nicotinicos del receptor para acetilcolina y/o de ligandos serotoninergicos, un procedimiento para su preparacion, las composiciones farmaceuticas que los contienen, y el empleo de los mismos para pInfo
- Publication number
- AR033624A1 AR033624A1 ARP020101529A ARP020101529A AR033624A1 AR 033624 A1 AR033624 A1 AR 033624A1 AR P020101529 A ARP020101529 A AR P020101529A AR P020101529 A ARP020101529 A AR P020101529A AR 033624 A1 AR033624 A1 AR 033624A1
- Authority
- AR
- Argentina
- Prior art keywords
- hal
- ligands
- cycloalkyl
- mono
- disease
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Abstract
Se describen derivados del dihidro-imidazo[4,5-e]indol y de la 7H-pirrolo[3,2-f]quinoxalina, de formula general (1) en donde: A-B-D representa -NR6-CR2=N-, -N=CR2-NR6- o -N=CR7-CR8=N-; R1 representa H o Het1; R2 representa H, A, cicloalquilo, -(CH2)n-N(R5)2, -(CH2)n-OR5, -(CH2)n-Ar o -(CH2)n-Het; R3 representa H, Hal, OH, OA o O-(CH2)n-Ar; R4 representa H, A o -(CH2)n-Ar; R5 representa H o A; R6, R7 y R8 representan independientemente H, A o -(CH2)n-Ar; R7 y R8, juntos, también representan alquileno C3-6; A representa un grupo alquilo C1-10 de cadena recta o ramificada; Ar representa fenilo, naftilo o bifenilo no sustituido o sustituido una o varias veces con Hal, A, OR5, N(R5)2, NO2, CN, COOR5, CON(R5)2, NR5COR5, NR5CON(R5)2, NR5SO2A, COR5, SO2NR5 o S(O)mA; cicloalquilo representa un cicloalquilo C3-10; Hal representa F, CL, Br o I; Het representa un resto heterocíclico saturado, insaturado o aromático, que contiene 5 a 10 miembros en el anillo, que puede presentar 1 a 4 átomos de N y/o 1 a 4 átomos de S y/o 1 a 4 átomos de O, y que puede estar mono, di o trisustituido con Hal, A, -[C(R5)2]o-Ar, [C(R5)2]o-cicloalquilo, OR5, N(R5)2, NO2, CN, COOR5, CON(R5)2, NR5COA, NR5CON(R5)2, NR5SO2A, COR5, SO2NR5 o S(O)mA y/o carboniloxi; Het1 representa un resto heterocíclico saturado, insaturado o aromático, mono, di o tricíclico, con 5 a 10 miembros en el anillo, que contiene al menos 1 átomo de N y que puede estar mono, di o trisustituido con Hal, A, OR5, N(R5)2, NO2, CN y/o carboniloxi; n es 0, 1, 2, 3, 4, 5, 6, 7 u 8; m es 1 o 2; o es 0, 1, 2, 3 o 4; y sus sales y solvatos aceptables desde el punto de vista fisiologico. Estos compuestos son ligandos del receptor nicotínico para acetilcolina y/o ligandos serotoninérgicos. También se describe un procedimiento para preparar estos compuestos, las composiciones farmacéuticas que los contienen y el uso de los mismos para preparar un medicamento destinado a la profilaxis o al tratamiento de las psicosis, la esquizofrenia, la depresion, los estados de pánico, la demencia, en particular la enfermedad de Alzheimer y la demencia por cuerpos de Lewy, las enfermedades neurodegenerativas, el mal de Parkinson, la esclerosis lateral amiotrofica, la enfermedad de Huntington, el síndrome de Tourette, la pérdida de la memoria y los trastornos en el aprendizaje, la bulimia, la anorexia nerviosa u otros trastornos alimenticios, los comportamientos obsesivos, el síndrome premenstrual, la amnesia senil, el alivio de los síntomas de abstinencia en la dependencia de la nicotina, el ataque de apoplejía o el dano cerebral por compuestos toxicos, y al tratamiento de enfermedades caracterizadas por un exceso de serotonina circulante o por una hiperfuncion serotoninérgica.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10121215A DE10121215A1 (de) | 2001-04-30 | 2001-04-30 | Dihydro-imidazo[4,5-e]indol- und 7H-Pyrrolo[3,2-f]chinoxalin Derivate als nikotinische Acetylcholinrezeptor Liganden und/oder serotonerge Liganden |
Publications (1)
Publication Number | Publication Date |
---|---|
AR033624A1 true AR033624A1 (es) | 2003-12-26 |
Family
ID=7683301
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP020101529A AR033624A1 (es) | 2001-04-30 | 2002-04-26 | Derivados del dihidro-imidazo[4,5-e]indol y de la 7h-pirrolo[3,2-f]quinoxalina en calidad de ligandos nicotinicos del receptor para acetilcolina y/o de ligandos serotoninergicos, un procedimiento para su preparacion, las composiciones farmaceuticas que los contienen, y el empleo de los mismos para p |
Country Status (13)
Country | Link |
---|---|
US (1) | US7279496B2 (es) |
EP (1) | EP1383774B1 (es) |
JP (1) | JP4593879B2 (es) |
AR (1) | AR033624A1 (es) |
AT (1) | ATE394404T1 (es) |
AU (1) | AU2002310904B2 (es) |
CA (1) | CA2445834C (es) |
CZ (1) | CZ20033195A3 (es) |
DE (2) | DE10121215A1 (es) |
ES (1) | ES2303857T3 (es) |
HU (1) | HUP0304046A2 (es) |
SK (1) | SK14472003A3 (es) |
WO (1) | WO2002088143A2 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2482639A1 (en) * | 2002-05-30 | 2003-12-11 | Neurosearch A/S | 3-substituted quinuclidines and their use |
US20050171079A1 (en) * | 2004-02-04 | 2005-08-04 | Schrimpf Michael R. | Amino-substituted tricyclic derivatives and methods of use |
JP5833804B2 (ja) | 2005-04-13 | 2015-12-16 | ニューラクソン,インコーポレーテッド | Nos阻害活性を有する置換インドール化合物 |
US7897766B2 (en) * | 2005-09-23 | 2011-03-01 | Abbott Laboratories | Amino-aza-adamantane derivatives and methods of use |
CA2643822A1 (en) * | 2006-04-13 | 2007-10-25 | Neuraxon, Inc | 1,5 and 3,6- substituted indole compounds having nos inhibitory activity |
EP2220074A4 (en) * | 2007-11-16 | 2012-01-04 | Neuraxon Inc | 3,5-SUBSTITUTED INDOL COMPOUNDS WITH NOS AND NOREPINEPHRINE RECOVERY-HEMDERING EFFECT |
US20090163451A1 (en) * | 2007-11-16 | 2009-06-25 | Frank Porreca | Methods for treating visceral pain |
AU2008323526A1 (en) * | 2007-11-16 | 2009-05-22 | Neuraxon, Inc. | Indole compounds and methods for treating visceral pain |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4009565A1 (de) * | 1990-03-24 | 1991-09-26 | Merck Patent Gmbh | Indolderivate |
EP0664807B1 (en) * | 1992-10-13 | 1997-09-10 | Warner-Lambert Company | Quinoxalinedione derivatives as eaa antagonists |
US5843945A (en) * | 1993-05-13 | 1998-12-01 | Neurosearch A/S | AMPA antagonists and a method of treatment |
JP3439215B2 (ja) * | 1993-05-13 | 2003-08-25 | ノイロサーチ アクティーゼルスカブ | Ampa拮抗薬およびそれを用いての治療方法 |
WO1997012862A1 (en) * | 1995-10-03 | 1997-04-10 | The Scripps Research Institute | Cbi analogs of cc-1065 and the duocarmycins |
CA2321559A1 (en) * | 1998-02-26 | 1999-09-02 | Ortho-Mcneil Pharmaceutical, Inc. | Substituted pyrrolobenzimidazoles for treating inflammatory diseases |
-
2001
- 2001-04-30 DE DE10121215A patent/DE10121215A1/de not_active Withdrawn
-
2002
- 2002-03-30 ES ES02735200T patent/ES2303857T3/es not_active Expired - Lifetime
- 2002-03-30 AU AU2002310904A patent/AU2002310904B2/en not_active Ceased
- 2002-03-30 EP EP02735200A patent/EP1383774B1/en not_active Expired - Lifetime
- 2002-03-30 US US10/476,234 patent/US7279496B2/en not_active Expired - Fee Related
- 2002-03-30 AT AT02735200T patent/ATE394404T1/de not_active IP Right Cessation
- 2002-03-30 JP JP2002585441A patent/JP4593879B2/ja not_active Expired - Fee Related
- 2002-03-30 HU HU0304046A patent/HUP0304046A2/hu unknown
- 2002-03-30 SK SK1447-2003A patent/SK14472003A3/sk unknown
- 2002-03-30 CA CA2445834A patent/CA2445834C/en not_active Expired - Fee Related
- 2002-03-30 DE DE60226428T patent/DE60226428D1/de not_active Expired - Lifetime
- 2002-03-30 WO PCT/EP2002/003582 patent/WO2002088143A2/en active IP Right Grant
- 2002-03-30 CZ CZ20033195A patent/CZ20033195A3/cs unknown
- 2002-04-26 AR ARP020101529A patent/AR033624A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1383774A2 (en) | 2004-01-28 |
EP1383774B1 (en) | 2008-05-07 |
CA2445834A1 (en) | 2002-11-07 |
JP4593879B2 (ja) | 2010-12-08 |
AU2002310904B2 (en) | 2008-01-10 |
WO2002088143A2 (en) | 2002-11-07 |
DE10121215A1 (de) | 2002-10-31 |
JP2004529936A (ja) | 2004-09-30 |
DE60226428D1 (de) | 2008-06-19 |
WO2002088143A3 (en) | 2003-01-23 |
ES2303857T3 (es) | 2008-09-01 |
SK14472003A3 (sk) | 2004-04-06 |
US20040142935A1 (en) | 2004-07-22 |
CA2445834C (en) | 2011-06-28 |
HUP0304046A2 (hu) | 2004-04-28 |
US7279496B2 (en) | 2007-10-09 |
ATE394404T1 (de) | 2008-05-15 |
CZ20033195A3 (cs) | 2004-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2010298166B2 (en) | Pyrido[4,3-b]indoles and methods of use | |
CA2820362C (en) | Substituted pyrazolopyrimidines as glucocerebrosidase activators | |
PE20230249A1 (es) | Compuestos de heteroarilo biciclicos y usos de estos | |
KR101689394B1 (ko) | 신규한 선택적인 히스톤탈아세틸화 효소 억제제로서의 아자인돌 유도체 및 이를 포함하는 약제학적 조성물 | |
AR054560A1 (es) | Espiropiperidina como inhibidores de beta-secretasa para el tratamiento de la enfermedad de alzheimer | |
MX2015015893A (es) | 2-fenilimidazo[1,2-a]pirimidinas como agentes formadores de imagen. | |
DE602006006850D1 (de) | Als modulatoren von dopamin-d3-rezeptoren geeignete azabicyclo-(3,1,0)-hexan-derivate | |
PE20220567A1 (es) | Nuevos derivados piperidinilo, un proceso para su preparacion y composiciones farmaceuticas que los contienen | |
AR049284A1 (es) | Compuestos derivados de 1,3-tiazol; composiciones farmaceuticas que los contienen y su uso en la preparacion de medicamentos para el tratamiento de enfermedades asociadas a la actividad de los ppard | |
BR0312312A (pt) | Composto, formulação farmacêutica, uso de um composto, processo para a preparação de compostos, e, intermediários | |
UY27336A1 (es) | Derivados de 4-piperacinilindol con afinidad receptora de 5-ht6 | |
PE20010130A1 (es) | Derivados de 3(5)-amino-pirazol y procedimiento para su preparacion | |
AR060633A1 (es) | Derivados de furo[3, 2-d]pirimidina, furo[2, 3-d]pirimidina, tieno[3, 2-d]pirimidina y tieno[2, 3-d]pirimidina, metodos para su preparacion, composiciones farmaceuticas y obtencion de las mismas, el uso de estos derivados en la fabricacion de medicamentos, kits y productos para el tratamiento de enf | |
ECSP034475A (es) | Derivados de 4-fenil-piridin como antagonistas del receptor de neuroquinina-1 | |
BR0211206A (pt) | Derivados de 8-metóxi-(1,2,4)triazolo(1, 5-a)piridina e seus usos como ligantes do receptor de adenosina | |
AR064608A1 (es) | Derivados de pirazolo-quinazolina sustituidos, composiciones farmaceuticas que los contienen. proceso para su preparacion y uso de los mismos como agentes anticancer. | |
AR033624A1 (es) | Derivados del dihidro-imidazo[4,5-e]indol y de la 7h-pirrolo[3,2-f]quinoxalina en calidad de ligandos nicotinicos del receptor para acetilcolina y/o de ligandos serotoninergicos, un procedimiento para su preparacion, las composiciones farmaceuticas que los contienen, y el empleo de los mismos para p | |
PE20030761A1 (es) | Derivados del 7-amino-benzotiazol | |
EP2480081A1 (en) | Bridged heterocyclic compounds and methods of use | |
AR043051A1 (es) | Compuestos de tiazol para el tratamiento de trastornos neurodegenerativos | |
KR20200096570A (ko) | 알츠하이머병과 같은 타우 응집체와 연관된 장애의 치료, 완화 또는 예방을 위한 1,3,4,5-테트라히드로-2h-피리도[4,3-b]인돌 유도체 | |
AR047369A1 (es) | N-cicloalquil, aril o heteroaril-n??-quinolin-2-ilcicloalquildiaminas, procesos para preparar tales compuestos y composiciones farmaceuticas que las contienen | |
ECSP034851A (es) | Derivados imidazo[1,5-a]pirimido[5,4-d]benzazepina como moduladores del receptor gaba a | |
AR065863A1 (es) | Derivados de imidazolidinona | |
AR069306A1 (es) | Derivados de metil- bencimidazol como moduladores de receptor x de farnesoide(fxr) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |